Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.35 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.35 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.33 |
| ▸ | KIF11 | P52732 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.31 |
| ▸ | GFER | P55789 | 1/20 | 0.31 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.31 |
| ▸ | HTR2A | P28223 | 1/20 | 0.31 |
| ▸ | BCHE | P06276 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL41595 | 0.90 | HSP90AA1 (0.35) | HSP90AA1HSP90AB1CYP17A1KIF11HPGD | |
| SCHEMBL15281929 | 0.83 | CHRM2 (0.32) | HSP90AA1HSP90AB1CYP2D6CYP2C19 | |
| SCHEMBL2397416 | 0.81 | — | — | |
| SCHEMBL9160477 | 0.78 | MAOA (0.39) | HPGDHSD17B10HTR2ALMNAKDM4E | |
| SCHEMBL36333 | 0.78 | MAOA (0.39) | HPGDHSD17B10HTR2ALMNAKDM4E | |
| SCHEMBL10476775 | 0.78 | MAOA (0.39) | HPGDHSD17B10HTR2ALMNAKDM4E | |
| SCHEMBL1037618 | 0.78 | ALDH1A1 (0.34) | HPGDHTR2AACHELMNAKDM4E | |
| Hydrochloric Acid SCHEMBL585839 | 0.76 | MAOA (0.37) | HPGDHSD17B10HTR2ALMNAKDM4E | |
| Ammonia Solution, Strong SCHEMBL1871983 | 0.76 | MAOA (0.37) | HPGDHSD17B10HTR2ALMNAKDM4E | |
| SCHEMBL11046607 | 0.76 | USP2 (0.36) | CYP17A1HPGDHSD17B10ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1219238-C | Positive resist composition | SUMITOMO CHEMICAL CO (JP) | 2005-09-14 | — | — | CN | claimed |
| US-6815140-B2 | COMPRISING A NOVOLAC RESIN, A RADIATION-SENSITIVE QUINONEDIAZIDE COMPOUND, AND ALSO A THIOXANTHONE COMPOUND TO IMPROVE RESOLUTION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2004-11-09 | — | — | US | claimed |
| US-20020006574-A1 | Comprising a novolac resin, a radiation-sensitive quinonediazide compound, and also a thioxanthone compound to improve resolution | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-01-17 | — | — | US | claimed |
| US-20010026905-A1 | Positive resist composition | SUMITOMO CHEMICAL COMPANY, LIMITED | 2001-10-04 | — | — | US | claimed |
| EP-0962826-A1 | A positive resist composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1999-12-08 | — | — | EP | claimed |
| CN-1237719-A | Positive resist composition | SUMITOMO CHEMICAL CO (JP) | 1999-12-08 | — | — | CN | claimed |
| CN-114105943-A | 3-substituted thioxanthone compound, preparation method thereof and application of photopolymerization system | 深圳有为技术控股集团有限公司 | 2022-03-01 | — | — | CN | disclosed |
| US-10928728-B2 | Photoactivable nitrogen bases | BASF SE (DE) | 2021-02-23 | — | — | US | disclosed |
| US-20210033972-A1 | PHOTOACTIVABLE NITROGEN BASES | BASF SE (DE) | 2021-02-04 | — | — | US | disclosed |
| EP-3440049-A1 | TRIMETHYLOLPROPANE DERIVATIVES | BASF SE (DE) | 2019-02-13 | — | — | EP | disclosed |
| US-20180217498-A1 | PHOTOACTIVABLE NITROGEN BASES | BASF SE (DE) | 2018-08-02 | — | — | US | disclosed |
| US-9921477-B2 | Photoactivable nitrogen bases | BASE SE (DE) | 2018-03-20 | — | — | US | disclosed |
| CN-104558596-B | Nitrogen-containing polyfunctionality acrylate resin, preparation method and application thereof | 乐凯华光印刷科技有限公司 | 2017-02-01 | — | — | CN | disclosed |
| WO-2003091287-A1 | INCORPORABLE PHOTOINITIATOR | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2003-11-06 | — | — | WO | disclosed |
| WO-2003089479-A2 | CURING OF COATINGS INDUCED BY PLASMA | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2003-10-30 | — | — | WO | disclosed |
| WO-2003033500-A1 | PHOTOACTIVABLE NITROGEN BASES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2003-04-24 | — | — | WO | disclosed |
| US-20020006574-A1 | Comprising a novolac resin, a radiation-sensitive quinonediazide compound, and also a thioxanthone compound to improve resolution | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-01-17 | — | — | US | disclosed |
| US-20010026905-A1 | Positive resist composition | SUMITOMO CHEMICAL COMPANY, LIMITED | 2001-10-04 | — | — | US | disclosed |
| EP-0962826-A1 | A positive resist composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1999-12-08 | — | — | EP | disclosed |
| CN-1237719-A | Positive resist composition | SUMITOMO CHEMICAL CO (JP) | 1999-12-08 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210033972-A1 | PHOTOACTIVABLE NITROGEN BASES | CBR1, ARNT, NR0B1 | HSP90AA1 3708/4885HSP90AB1 3589/4885CYP17A1 258/4885 |
| US-10928728-B2 | Photoactivable nitrogen bases | CBR1, NR0B1, NR0B2 | HSP90AA1 3862/4885HSP90AB1 3783/4885CYP17A1 366/4885 |
| US-20180217498-A1 | PHOTOACTIVABLE NITROGEN BASES | CBR1, NR0B1, NR0B2 | HSP90AA1 3862/4885HSP90AB1 3783/4885CYP17A1 366/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.